Evidence map›Paper›PMID 21256604›Full record

ReviewTrends in neurosciences2011

Kainate receptors coming of age: milestones of two decades of research.

Anis Contractor, Christophe Mulle, Geoffrey T Swanson

Open access · bronzeAbstract readReview
In one paragraph

Review in Trends in neurosciences, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 156 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
156citing papers in PubMed, 1 pooled it
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

156 citing papers in PubMed, 1 synthesis or guideline pooled it, 289 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. A novel AAV9-dual microRNA-vector targetingMolecular therapy. Methods & clinical development · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

96 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Anis ContractorDepartment of Physiology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. a-contractor@northwestern.edu
Christophe Mulle
Geoffrey T Swanson
Northwestern University · USUniversité de Bordeaux · FR

Funding

Novel marine-derived ligands for probing GluR functionR01NS044322 · NINDS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI SWANSON, GEOFFREY T · 2002 to 2011
$2.6M
Kainate receptor signaling at excitatory synapsesR01NS058894 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CONTRACTOR, ANIS · 2008 to 2011
$1.3M
Role of 4.1 proteins in kainate receptor localization and functionR01NS071952 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SWANSON, GEOFFREY T · 2010 to 2013
$1.3M
NINDS NIH HHS R01 NS044322NINDS NIH HHS R01NS044322NINDS NIH HHS R01 NS058894NINDS NIH HHS R01NS058894NINDS NIH HHS R01 NS071952
6 · The paper itself

Abstract

Two decades have passed since the first report of the cloning of a kainate-type glutamate receptor (KAR) subunit. The intervening years have seen a rapid growth in our understanding of the biophysical properties and function of KARs in the brain. This research has led to an appreciation that KARs play very distinct roles at synapses relative to other members of the glutamate-gated ion channel receptor family, despite structural and functional commonalities. The surprisingly diverse and complex nature of KAR signaling underlies their unique impact upon neuronal networks through their direct and indirect effects on synaptic transmission, and their prominent role in regulating cell excitability. This review pieces together highlights from the two decades of research subsequent to the cloning of the first subunit, and provides an overview of our current understanding of the role of KARs in the CNS and their potential importance to neurological and neuropsychiatric disorders.

Indexed as

AnimalsDisease Models, AnimalDrug Delivery SystemsHumansKainic Acid ReceptorsNeurosciencesKainic Acid Receptors

Identifiers

PMID21256604
PMCPMC3051042
OpenAlexW2138295391

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.